Journal of Clinical Endocrinology & Metabolism, Vol 71, 1202-1207, Copyright © 1990 by Endocrine Society

ARTICLES

Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration

A Tar, JF Hocquette, JC Souberbielle, JP Clot, R Brauner and MC Postel-Vinay
Unite de Biologie et Pathologie de la Croissance et du Developpement, INSERM Unite 30, Hopital des Enfants-Malades, Paris, France.

A technique using high pressure liquid chromatography gel filtration was used to evaluate GH-binding proteins (BP) in human plasma; eluate was monitored for radioactivity in a gamma-detection system connected to a computer. Plasma (200 microL) was incubated with [125I]human (h) GH (200,000 cpm) at 4 C for 20 h. The main GH-BP (peak II) was well separated from free [125I]hGH (peak III) and from a higher mol wt complex (peak I), which was minor. In our control plasma, the specific binding of [125I]hGH to peak II BP (II-BP) was 32.2 +/- 0.6% of the radioactivity. Scatchard analyses indicate an association constant of 3.6-7.4 X 10(8) M-1 and a binding capacity ranging from 24-86 ng/mL for peak II-BP in five normal adult plasma samples. Peak I material, separated from plasma of boys with pubertal delay, bound hGH with a low affinity (3 x 10(6) M-1) and a very high capacity (2 micrograms/mL). In cross-linking experiments, peak I appeared as two proteins of 165 and 174 kD; these mol wt were much higher than that of peak II-BP, previously estimated at 53,000. hGH complexed to peak II-BP remained fully immunoreactive with use of the anti-hGH antibodies of our assay. In plasma containing 10-20 micrograms/L hGH, the proportion of bound hormone (peak II) was 44.5 +/- 2.3%, whereas the amount of hGH in peak I was very low or undetectable. Specific binding of hGH to II-BP was lowest during the first year of life and highest in adulthood. No sex difference was found. I-BP is differentially regulated, since its binding activity was significantly lower in adults than in prepubertal children. Normal values for age should be taken into account to interpret GH-binding activity, particularly in children 2 yr of age or younger. Our GH binding assay offers important gains in terms of rapidity and resolution; it has permitted a clear separation and characterization of the two GH-binding components present in human plasma.

This article has been cited by other articles:

				A. Milward, L. Metherell, M. Maamra, M. J. Barahona, I. R. Wilkinson, C. Camacho-Hubner, M. O. Savage, C. M. Bidlingmaier, A. J. L. Clark, R. J. M. Ross, et al. Growth Hormone (GH) Insensitivity Syndrome due to a GH Receptor Truncated after Box1, Resulting in Isolated Failure of STAT 5 Signal Transduction J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1259 - 1266. [Abstract] [Full Text] [PDF]

				T. Amit, M. B. H. Youdim, and Z.'e. Hochberg Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function? J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932. [Abstract] [Full Text]

				K.-C. Leung, N. Doyle, and K. K. Y. Ho Characterization of a Low Affinity Binding Protein for Growth Hormone in Rat Serum Endocrinology, January 1, 2000; 141(1): 138 - 145. [Abstract] [Full Text] [PDF]

				N. D. Quinton, R. F. Smith, P. E. Clayton, M. S. Gill, S. Shalet, S. K. Justice, S. A. Simon, S. Walters, M.-C. Postel-Vinay, A. I. F. Blakemore, et al. Leptin Binding Activity Changes with Age: The Link between Leptin and Puberty J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2336 - 2341. [Abstract] [Full Text]

				J.-L. Bresson, S. Jeay, M.-C. Gagnerault, C. Kayser, N. Beressi, Z. Wu, S. Kinet, M. Dardenne, and M.-C. Postel-Vinay Growth Hormone (GH) and Prolactin Receptors in Human Peripheral Blood Mononuclear Cells: Relation with Age and GH-Binding Protein Endocrinology, July 1, 1999; 140(7): 3203 - 3209. [Abstract] [Full Text]

				Y.-N. Sun, H. J. Lee, R. R. Almon, and W. J. Jusko A Pharmacokinetic/Pharmacodynamic Model for Recombinant Human Growth Hormone Effects on Induction of Insulin-Like Growth Factor I in Monkeys J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1523 - 1532. [Abstract] [Full Text]

				M. A. Llopis, M. L. Granada, G. Cuatrecasas, X. Formiguera, L. Sánchez-Planell, A. SanmartÍ, A. Alastrué, M. Rull, A. Corominas, and M. Foz Growth Hormone-Binding Protein Directly Depends on Serum Leptin Levels in Adults with Different Nutritional Status J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2006 - 2011. [Abstract] [Full Text]

				G. Touati, A. M. Prieur, J. C. Ruiz, M. Noel, and P. Czernichow Beneficial Effects of One-Year Growth Hormone Administration to Children with Juvenile Chronic Arthritis on Chronic Steroid Therapy. I. Effects on Growth Velocity and Body Composition J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 403 - 409. [Abstract] [Full Text]

				K. A. Woods, F. Dastot, M. A. Preece, A. J. L. Clark, M.-C. Postel-Vinay, P. G. Chatelain, M. B. Ranke, R. G. Rosenfeld, S. Amselem, and M. O. Savage Phenotype: Genotype Relationships in Growth Hormone Insensitivity Syndrome J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3529 - 3535. [Abstract] [Full Text] [PDF]

				S. Combes, I. Louveau, and M. Bonneau Moderate Food Restriction Affects Skeletal Muscle and Liver Growth Hormone Receptors Differently in Pigs J. Nutr., October 1, 1997; 127(10): 1944 - 1949. [Abstract] [Full Text]

				J.-F. Martini, A. Pezet, C. Y. Guezennec, M. Edery, M.-C. Postel-Vinay, and P. A. Kelly Monkey Growth Hormone (GH) Receptor Gene Expression. EVIDENCE FOR TWO MECHANISMS FOR THE GENERATION OF THE GH BINDING PROTEIN J. Biol. Chem., July 25, 1997; 272(30): 18951 - 18958. [Abstract] [Full Text] [PDF]

				M. Perrot-Applanat, O. Gualillo, A. Pezet, V. Vincent, M. Edery, and P. A. Kelly Dominant Negative and Cooperative Effects of Mutant Forms of Prolactin Receptor Mol. Endocrinol., July 1, 1997; 11(8): 1020 - 1032. [Abstract] [Full Text]

				R. J. M. Ross, N. Esposito, X. Y. Shen, S. Von Laue, S. L. Chew, P. R. M. Dobson, M.-C. Postel-Vinay, and J. Finidori A Short Isoform of the Human Growth Hormone Receptor Functions as a Dominant Negative Inhibitor of the Full-Length Receptor and Generates Large Amounts of Binding Protein Mol. Endocrinol., March 1, 1997; 11(3): 265 - 273. [Abstract] [Full Text]

				J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF]